The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity

Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. H...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Obesity Vol. 42; no. 3; pp. 441 - 447
Main Authors Rayner, J J, Banerjee, R, Holloway, C J, Lewis, A J M, Peterzan, M A, Francis, J M, Neubauer, S, Rider, O J
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2018
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Methods: Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4–53.0 kg m −2 ) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Results: Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r =−0.46, P =0.001). Myocardial triglyceride content (β=−0.2, P =0.008), PCr/ATP (β=−0.22, P =0.04) and LV mass:volume ratio (β=−0.61, P =0.04) all independently predicted peak diastolic strain rate (model R 2 0.36, P <0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Conclusions: Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
AbstractList Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m ) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Methods: Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m[sup.-2]) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Results: Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content ([beta]=-0.2, P=0.008), PCr/ATP ([beta]=-0.22, P=0.04) and LV mass:volume ratio ([beta]=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R[sup.2] 0.36, P [less than] 0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Conclusions: Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. International Journal of Obesity (2018) 42, 441-447; doi: 10.1038/ijo.2017.239; published online 24 October 2017
Background:Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.Methods:Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m-2 ) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.Results:Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.Conclusions:Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m[sup.-2]) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content ([beta]=-0.2, P=0.008), PCr/ATP ([beta]=-0.22, P=0.04) and LV mass:volume ratio ([beta]=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R[sup.2] 0.36, P [less than] 0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.BACKGROUNDObesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m-2) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.METHODSEighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m-2) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.RESULTSIncreasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.CONCLUSIONSMyocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Methods: Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4–53.0 kg m −2 ) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Results: Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r =−0.46, P =0.001). Myocardial triglyceride content (β=−0.2, P =0.008), PCr/ATP (β=−0.22, P =0.04) and LV mass:volume ratio (β=−0.61, P =0.04) all independently predicted peak diastolic strain rate (model R 2 0.36, P <0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Conclusions: Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
Audience Academic
Author Holloway, C J
Neubauer, S
Rayner, J J
Peterzan, M A
Lewis, A J M
Francis, J M
Rider, O J
Banerjee, R
Author_xml – sequence: 1
  givenname: J J
  surname: Rayner
  fullname: Rayner, J J
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 2
  givenname: R
  surname: Banerjee
  fullname: Banerjee, R
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 3
  givenname: C J
  surname: Holloway
  fullname: Holloway, C J
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 4
  givenname: A J M
  surname: Lewis
  fullname: Lewis, A J M
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 5
  givenname: M A
  surname: Peterzan
  fullname: Peterzan, M A
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 6
  givenname: J M
  surname: Francis
  fullname: Francis, J M
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 7
  givenname: S
  surname: Neubauer
  fullname: Neubauer, S
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
– sequence: 8
  givenname: O J
  surname: Rider
  fullname: Rider, O J
  email: oliver.rider@gmail.com
  organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28974742$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9rHCEUx6WkNJu0t57LQKH00Nk64ziOl0II_QWBXtKzPB3ddXE0VSew_33d3aTJhhQPgn6-X_2-987QiQ9eI_S2wcsGk-Gz3YRlixu2bAl_gRZNx_qadpydoAUmmNWY9vQUnaW0wRhTittX6LQdOOtY1y7Q6nqtq6gdZHurKxV8jlbO2QZfBVNNOoMMzqoK_FilHGeV5wiuAulDnMDZbHWqcqhGCynvyXGbzOzV3sIWF6mTzdvX6KUBl_Sbu_0c_f729fryR3316_vPy4urWtFuyLUZjWRcA6FSdpIQowYDMPaEAVbjOCrNm563LRDVgyGK8LFE7yWn3DBCCTlHXw6-N7OcdOFLIHDiJtoJ4lYEsOL4xtu1WIVbQYcB0wEXg493BjH8mXXKYrJJaefA6zAn0fCOYc56tkPfP0E3YY6-xBOlIbxr6dCQB2oFTgvrTSjvqp2puKCk7TuCMS_U8hmqrFFPtrRFG1vOjwQfHgnWGlxep-D2rUvH4LvHFflXivsZKEB7AFQMKUVthLIZdj7lC9aJBovdoIkyaLtcTJRBK6JPT0T3vv_B6wOeCuZXOj6U6ln-L_nc5JE
CitedBy_id crossref_primary_10_1002_clc_23838
crossref_primary_10_1016_j_numecd_2020_07_011
crossref_primary_10_1007_s10557_022_07355_7
crossref_primary_10_1161_CIRCRESAHA_120_316101
crossref_primary_10_36660_abc_20200855
crossref_primary_10_3389_fphys_2021_785879
crossref_primary_10_1038_s41366_018_0263_2
crossref_primary_10_3390_medicina56100524
crossref_primary_10_1002_ejhf_1956
crossref_primary_10_2459_JCM_0000000000001397
crossref_primary_10_1152_physiol_00018_2023
crossref_primary_10_1002_ejhf_1617
crossref_primary_10_18087_cardio_2023_7_n2120
crossref_primary_10_20996_1819_6446_2020_02_09
crossref_primary_10_1038_s41467_023_44520_4
crossref_primary_10_1136_openhrt_2024_002711
crossref_primary_10_1002_mrm_28494
crossref_primary_10_1089_met_2018_0092
crossref_primary_10_1016_j_jchf_2020_04_016
crossref_primary_10_1016_j_pcad_2018_06_004
crossref_primary_10_1007_s11906_019_0939_6
crossref_primary_10_1016_j_hfc_2024_06_006
crossref_primary_10_1016_j_cardfail_2019_09_002
crossref_primary_10_1016_j_ijcard_2018_08_008
crossref_primary_10_1080_17446651_2018_1500894
crossref_primary_10_1016_j_ccl_2023_06_010
crossref_primary_10_3389_fendo_2023_1181452
crossref_primary_10_1093_ehjci_jeac270
crossref_primary_10_2147_JIR_S356038
crossref_primary_10_1016_j_soard_2021_09_009
crossref_primary_10_1113_EP091566
crossref_primary_10_3389_fendo_2024_1439691
crossref_primary_10_15275_rusomj_2022_0103
crossref_primary_10_1093_cvr_cvae139
crossref_primary_10_1093_eurjpc_zwad099
crossref_primary_10_1161_JAHA_122_029062
crossref_primary_10_1038_s41598_020_76497_1
crossref_primary_10_1002_nbm_5206
crossref_primary_10_1002_ejhf_1653
crossref_primary_10_3390_biomedicines10071519
crossref_primary_10_1111_echo_14838
crossref_primary_10_4093_dmj_2020_0221
crossref_primary_10_1007_s11695_025_07801_z
crossref_primary_10_1016_j_gtc_2023_03_006
crossref_primary_10_1016_j_yexmp_2024_104895
crossref_primary_10_1161_CIRCULATIONAHA_121_054858
crossref_primary_10_1152_physrev_00030_2020
crossref_primary_10_1186_s12968_018_0513_4
crossref_primary_10_1093_eurheartj_ehab663
crossref_primary_10_1007_s40675_019_00160_z
crossref_primary_10_1002_ajmg_a_63168
crossref_primary_10_1161_JAHA_123_030221
crossref_primary_10_1111_cob_12476
crossref_primary_10_1016_j_lfs_2023_122087
Cites_doi 10.1136/heart.89.10.1152
10.1152/ajpheart.00499.2004
10.1016/j.amjcard.2006.01.063
10.1161/ATVBAHA.115.306561
10.1016/0002-9149(64)90014-1
10.1210/en.2003-1128
10.1210/mend.11.4.9907
10.1016/j.amjcard.2004.02.073
10.1136/hrt.2009.185009
10.1056/NEJMoa020245
10.1007/s10554-012-0174-6
10.1136/heartjnl-2012-302145
10.1152/ajpheart.00579.2006
10.1016/j.bbalip.2009.12.006
10.1074/jbc.275.19.14563
10.1038/ijo.2012.170
10.1093/eurjhf/hfq159
10.1002/mrm.23011
10.1016/0002-9343(76)90499-X
10.1016/j.jacc.2009.02.086
10.1161/CIRCULATIONAHA.111.069518
10.1161/CIRCHEARTFAILURE.115.002883
10.1002/bmb.2006.49403403168
10.1067/mje.2003.40
10.1080/152165401753311780
10.1161/01.CIR.0000127959.28627.F8
10.1016/S0002-9149(97)00505-5
10.1097/00000441-200104000-00003
10.1016/j.amjcard.2013.05.036
10.1016/j.jcmg.2009.10.012
10.1073/pnas.97.4.1784
10.3758/BRM.40.3.879
10.1016/j.jcmg.2014.12.019
10.1016/j.cardiores.2006.06.024
10.1016/j.jacc.2003.10.062
10.1073/pnas.0405499101
10.1016/j.pcad.2005.02.010
10.1152/ajpendo.00093.2009
10.1161/01.CIR.93.4.800
10.1186/1532-429X-11-9
10.1210/jc.2004-1963
10.1161/CIRCRESAHA.116.306842
10.1161/01.RES.0000089255.37804.72
10.1016/j.ijcard.2012.03.104
10.1056/NEJMra063052
10.1152/ajpheart.2000.278.4.H1345
10.1093/eurheartj/ehs341
10.1016/j.cardiores.2005.11.022
ContentType Journal Article
Copyright The Author(s) 2018
COPYRIGHT 2018 Nature Publishing Group
Copyright Nature Publishing Group Mar 2018
Copyright © 2018 The Author(s) 2018 The Author(s)
Copyright_xml – notice: The Author(s) 2018
– notice: COPYRIGHT 2018 Nature Publishing Group
– notice: Copyright Nature Publishing Group Mar 2018
– notice: Copyright © 2018 The Author(s) 2018 The Author(s)
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7TK
7TS
7X2
7X7
7XB
88E
88G
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0K
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/ijo.2017.239
DatabaseName SpringerOpen
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Physical Education Index
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Public Health Database (subscription)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection (subscription)
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
Physical Education Index
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Biological Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Agricultural Science Database


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Diet & Clinical Nutrition
Recreation & Sports
DocumentTitleAlternate Relative contribution of metabolic and structural abnormalities
EISSN 1476-5497
EndPage 447
ExternalDocumentID PMC5880580
A532643009
28974742
10_1038_ijo_2017_239
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: British Heart Foundation
  grantid: FS/16/70/32157
– fundername: British Heart Foundation
  grantid: FS/08/074/26233
– fundername: British Heart Foundation
  grantid: FS/14/54/30946
GroupedDBID .55
.GJ
29J
36B
39C
5RE
7X2
7X7
8R4
8R5
A8Z
ABDBF
ABOCM
ABUWG
ACUHS
ADBBV
AFFNX
AI.
ALMA_UNASSIGNED_HOLDINGS
ATCPS
AZQEC
B0M
BAWUL
BENPR
BHPHI
BPHCQ
C6C
DIK
DWQXO
EAD
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
HCIFZ
IAO
IHR
ITC
J5H
M0K
M1P
M2M
MVM
NAO
OK1
Q2X
RNT
RNTTT
SV3
TUS
VH1
WH7
X7M
ZGI
ZXP
~8M
AAYXX
CITATION
---
-Q-
..I
.L3
.XZ
0R~
1CY
2FS
2WC
4.4
406
53G
5GY
70F
88E
8AO
8C1
8FE
8FH
8FI
8FJ
AACDK
AAHBH
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABRTQ
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACSTC
ACZOJ
ADHUB
ADXHL
AEFQL
AEJRE
AEMSY
AENEX
AEUYN
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
AMYLF
APEBS
ATHPR
AXYYD
AYFIA
BBNVY
BKKNO
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DNIVK
DPUIP
DU5
E3Z
EBLON
ECM
EE.
EIF
EIOEI
EJD
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
HMCUK
HZ~
IHW
INH
INR
IPY
IWAJR
JSO
JZLTJ
KQ8
L7B
M7P
NPM
NQJWS
O9-
OVD
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PSYQQ
RNS
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
UKHRP
~KM
3V.
7T2
7TK
7TS
7XB
8FK
C1K
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c548t-fdfb79ea35bb4b33fc8faad637a0cdddce916922a3c6af3c39d0176b959f73533
IEDL.DBID C6C
ISSN 0307-0565
1476-5497
IngestDate Thu Aug 21 18:14:21 EDT 2025
Fri Jul 11 10:50:18 EDT 2025
Wed Jul 16 16:06:21 EDT 2025
Tue Jun 17 21:47:05 EDT 2025
Tue Jun 10 20:50:11 EDT 2025
Thu May 22 21:23:18 EDT 2025
Mon Jul 21 06:04:04 EDT 2025
Tue Jul 01 03:01:58 EDT 2025
Thu Apr 24 22:57:14 EDT 2025
Fri Feb 21 02:39:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c548t-fdfb79ea35bb4b33fc8faad637a0cdddce916922a3c6af3c39d0176b959f73533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/ijo.2017.239
PMID 28974742
PQID 2019425813
PQPubID 38864
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5880580
proquest_miscellaneous_1947097670
proquest_journals_2019425813
gale_infotracmisc_A532643009
gale_infotracacademiconefile_A532643009
gale_healthsolutions_A532643009
pubmed_primary_28974742
crossref_citationtrail_10_1038_ijo_2017_239
crossref_primary_10_1038_ijo_2017_239
springer_journals_10_1038_ijo_2017_239
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-03-01
PublicationDateYYYYMMDD 2018-03-01
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle International Journal of Obesity
PublicationTitleAbbrev Int J Obes
PublicationTitleAlternate Int J Obes (Lond)
PublicationYear 2018
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Neubauer (CR26) 2007; 356
Rajapurohitam, Gan, Kirshenbaum, Karmazyn (CR42) 2003; 93
Zeidan, Javadov, Karmazyn (CR45) 2006; 72
Rider, Francis, Tyler, Byrne, Clarke, Neubauer (CR51) 2012; 29
Zeidan, Erbel, Barkhausen, Hunold, Bartel, Buck (CR19) 2003; 16
Rider, Francis, Ali, Holloway, Pegg, Robson (CR11) 2012; 125
Kossaify, Nicolas (CR13) 2013; 7
Abe, Ono, Kawamura, Wada, Kita, Shimatsu (CR44) 2007; 292
Peterson, Waggoner, Schechtman, Meyer, Gropler, Barzilai (CR9) 2004; 43
Hue, Taegtmeyer (CR29) 2009; 297
Rider, Lewandowski, Nethononda, Petersen, Francis, Pitcher (CR16) 2013; 34
Peterson, Herrero, Schechtman, Racette, Waggoner, Kisrieva-Ware (CR31) 2004; 109
Banks, Davis, Bates, Myers (CR46) 2000; 275
Rider, Petersen, Francis, Ali, Hudsmith, Robinson (CR39) 2011; 97
Veech (CR27) 2006; 34
Kenchaiah, Evans, Levy, Wilson, Benjamin, Larson (CR1) 2002; 347
Virtue, Vidal-Puig (CR32) 2010; 1801
Adamopoulos, Meyer, Desai, Karatzidou, Ovalle, White (CR22) 2011; 13
Madani, De Girolamo, Munoz, Li, Sweeney (CR41) 2006; 69
Rider, Francis, Ali, Petersen, Robinson, Robson (CR10) 2009; 54
Owan, Redfield (CR3) 2005; 47
Rial, Robson, Neubauer, Schneider (CR21) 2011; 66
Nelson, Victor, Szczepaniak, Simha, Garg, Szczepaniak (CR33) 2013; 112
Banerjee, Rial, Holloway, Lewandowski, Robson, Osuchukwu (CR17) 2015; 8
Cittadini, Stromer, Katz, Clark, Moses, Morgan (CR48) 1996; 93
Powell, Redfield, Bybee, Freeman, Rihal (CR4) 2006; 98
Holloway, Dass, Suttie, Rider, Cox, Cochlin (CR24) 2012; 98
Turkbey, McClelland, Kronmal, Burke, Bild, Tracy (CR37) 2010; 3
Ghilardi, Skoda (CR47) 1997; 11
Zhou, Grayburn, Karim, Shimabukuro, Higa, Baetens (CR50) 2000; 97
Utz, Engeli, Haufe, Kast, Bohnke, Haas (CR52) 2012; 167
Veech, Chance, Kashiwaya, Lardy, Cahill (CR28) 2001; 51
Rider, Francis, Tyler, Byrne, Clarke, Neubauer (CR15) 2013; 29
Tajmir, Ceddia, Li, Coe, Sweeney (CR43) 2004; 145
Lee, Naseem, Duplomb, Park, Garry, Richardson (CR49) 2004; 101
Purdham, Zou, Rajapurohitam, Karmazyn (CR40) 2004; 287
Alpert, Terry, Mulekar, Cohen, Massey, Fan (CR2) 1997; 80
Preacher, Hayes (CR25) 2008; 40
Rider, Banerjee, Rayner, Shah, Murthy, Robson (CR20) 2016; 36
Rider, Cox, Tyler, Clarke, Neubauer (CR18) 2013; 37
Alpert (CR35) 2001; 321
Kaltman, Goldring (CR7) 1976; 60
Eaton, Pettinger, Rossouw, Martin, Foraker, Quddus (CR14) 2016; 9
Alexander (CR6) 1964; 14
Perego, Pizzocri, Corradi, Maisano, Paganelli, Fiorina (CR38) 2005; 90
Rider, Francis, Ali, Byrne, Clarke, Neubauer (CR5) 2009; 11
Alexander (CR36) 1993; 2
Korvald, Elvenes, Myrmel (CR30) 2000; 278
Otto, Belohlavek, Khandheria, Gilman, Svatikova, Somers (CR8) 2004; 93
Pascual, Pascual, Soria, Vicente, Hernandez, Tebar (CR12) 2003; 89
Schulze, Drosatos, Goldberg (CR34) 2016; 118
Levelt, Rodgers, Clarke, Mahmod, Ariga, Francis (CR23) 2015; 65
JK Alexander (BFijo2017239_CR36) 1993; 2
L Hue (BFijo2017239_CR29) 2009; 297
JK Alexander (BFijo2017239_CR6) 1964; 14
S Kenchaiah (BFijo2017239_CR1) 2002; 347
BD Powell (BFijo2017239_CR4) 2006; 98
OJ Rider (BFijo2017239_CR11) 2012; 125
E Levelt (BFijo2017239_CR23) 2015; 65
RL Veech (BFijo2017239_CR27) 2006; 34
Y Abe (BFijo2017239_CR44) 2007; 292
Y Lee (BFijo2017239_CR49) 2004; 101
AJ Kaltman (BFijo2017239_CR7) 1976; 60
V Rajapurohitam (BFijo2017239_CR42) 2003; 93
LR Peterson (BFijo2017239_CR9) 2004; 43
AS Banks (BFijo2017239_CR46) 2000; 275
N Ghilardi (BFijo2017239_CR47) 1997; 11
MA Alpert (BFijo2017239_CR2) 1997; 80
A Kossaify (BFijo2017239_CR13) 2013; 7
EB Turkbey (BFijo2017239_CR37) 2010; 3
ME Otto (BFijo2017239_CR8) 2004; 93
S Madani (BFijo2017239_CR41) 2006; 69
TE Owan (BFijo2017239_CR3) 2005; 47
KJ Preacher (BFijo2017239_CR25) 2008; 40
OJ Rider (BFijo2017239_CR16) 2013; 34
R Banerjee (BFijo2017239_CR17) 2015; 8
OJ Rider (BFijo2017239_CR5) 2009; 11
S Virtue (BFijo2017239_CR32) 2010; 1801
Z Zeidan (BFijo2017239_CR19) 2003; 16
DM Purdham (BFijo2017239_CR40) 2004; 287
W Utz (BFijo2017239_CR52) 2012; 167
A Zeidan (BFijo2017239_CR45) 2006; 72
A Cittadini (BFijo2017239_CR48) 1996; 93
OJ Rider (BFijo2017239_CR51) 2012; 29
L Perego (BFijo2017239_CR38) 2005; 90
OJ Rider (BFijo2017239_CR20) 2016; 36
PC Schulze (BFijo2017239_CR34) 2016; 118
CB Eaton (BFijo2017239_CR14) 2016; 9
OJ Rider (BFijo2017239_CR10) 2009; 54
OJ Rider (BFijo2017239_CR15) 2013; 29
B Rial (BFijo2017239_CR21) 2011; 66
YT Zhou (BFijo2017239_CR50) 2000; 97
M Pascual (BFijo2017239_CR12) 2003; 89
LR Peterson (BFijo2017239_CR31) 2004; 109
MD Nelson (BFijo2017239_CR33) 2013; 112
OJ Rider (BFijo2017239_CR39) 2011; 97
CJ Holloway (BFijo2017239_CR24) 2012; 98
OJ Rider (BFijo2017239_CR18) 2013; 37
MA Alpert (BFijo2017239_CR35) 2001; 321
S Neubauer (BFijo2017239_CR26) 2007; 356
RL Veech (BFijo2017239_CR28) 2001; 51
C Adamopoulos (BFijo2017239_CR22) 2011; 13
P Tajmir (BFijo2017239_CR43) 2004; 145
C Korvald (BFijo2017239_CR30) 2000; 278
31227797 - Int J Obes (Lond). 2019 Aug;43(8):1652. doi: 10.1038/s41366-019-0404-2.
References_xml – volume: 89
  start-page: 1152
  year: 2003
  end-page: 1156
  ident: CR12
  article-title: Effects of isolated obesity on systolic and diastolic left ventricular function
  publication-title: Heart
  doi: 10.1136/heart.89.10.1152
– volume: 287
  start-page: H2877
  year: 2004
  end-page: H2884
  ident: CR40
  article-title: Rat heart is a site of leptin production and action
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00499.2004
– volume: 98
  start-page: 116
  year: 2006
  end-page: 120
  ident: CR4
  article-title: Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.01.063
– volume: 36
  start-page: 198
  year: 2016
  end-page: 203
  ident: CR20
  article-title: Investigating a liver fat: arterial stiffening pathway in adult and childhood obesity
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.115.306561
– volume: 14
  start-page: 860
  year: 1964
  end-page: 865
  ident: CR6
  article-title: Obesity and cardiac performance
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(64)90014-1
– volume: 145
  start-page: 1550
  year: 2004
  end-page: 1555
  ident: CR43
  article-title: Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways
  publication-title: Endocrinology
  doi: 10.1210/en.2003-1128
– volume: 11
  start-page: 393
  year: 1997
  end-page: 399
  ident: CR47
  article-title: The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.11.4.9907
– volume: 93
  start-page: 1569
  year: 2004
  end-page: 1572
  ident: CR8
  article-title: Comparison of right and left ventricular function in obese and nonobese men
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.02.073
– volume: 97
  start-page: 203
  year: 2011
  end-page: 208
  ident: CR39
  article-title: Ventricular hypertrophy and cavity dilatation in relation to body mass index in females with uncomplicated obesity
  publication-title: Heart
  doi: 10.1136/hrt.2009.185009
– volume: 347
  start-page: 305
  year: 2002
  end-page: 313
  ident: CR1
  article-title: Obesity and the risk of heart failure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa020245
– volume: 29
  start-page: 1043
  year: 2012
  end-page: 1050
  ident: CR51
  article-title: Effects of weight loss on myocardial energetics and diastolic function in obesity
  publication-title: Int J Cardiovasc Imaging
  doi: 10.1007/s10554-012-0174-6
– volume: 98
  start-page: 1083
  year: 2012
  end-page: 1090
  ident: CR24
  article-title: Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism
  publication-title: Heart
  doi: 10.1136/heartjnl-2012-302145
– volume: 292
  start-page: H2387
  year: 2007
  end-page: H2396
  ident: CR44
  article-title: Leptin induces elongation of cardiac myocyte and causes eccentric left ventricular dilatation with compensation
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00579.2006
– volume: 1801
  start-page: 338
  year: 2010
  end-page: 349
  ident: CR32
  article-title: Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbalip.2009.12.006
– volume: 275
  start-page: 14563
  year: 2000
  end-page: 14572
  ident: CR46
  article-title: Activation of downstream signals by the long form of the leptin receptor
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.19.14563
– volume: 37
  start-page: 972
  year: 2013
  end-page: 979
  ident: CR18
  article-title: Myocardial substrate metabolism in obesity
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2012.170
– volume: 13
  start-page: 200
  year: 2011
  end-page: 206
  ident: CR22
  article-title: Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study
  publication-title: Eur J Heart Fail
  doi: 10.1093/eurjhf/hfq159
– volume: 66
  start-page: 619
  year: 2011
  end-page: 624
  ident: CR21
  article-title: Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.23011
– volume: 60
  start-page: 645
  year: 1976
  end-page: 653
  ident: CR7
  article-title: Role of circulatory congestion in the cardiorespiratory failure of obesity
  publication-title: Am J Med
  doi: 10.1016/0002-9343(76)90499-X
– volume: 54
  start-page: 718
  year: 2009
  end-page: 726
  ident: CR10
  article-title: Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.02.086
– volume: 125
  start-page: 1511
  year: 2012
  end-page: 1519
  ident: CR11
  article-title: Effects of catecholamine stress on diastolic function and myocardial energetics in obesity
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.069518
– volume: 9
  start-page: pii: e002883
  year: 2016
  ident: CR14
  article-title: Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.115.002883
– volume: 34
  start-page: 168
  year: 2006
  end-page: 179
  ident: CR27
  article-title: The determination of the redox states and phosphorylation potential in living tissues and their relationship to metabolic control of disease phenotypes
  publication-title: Biochem Mol Biol Educ
  doi: 10.1002/bmb.2006.49403403168
– volume: 16
  start-page: 29
  year: 2003
  end-page: 37
  ident: CR19
  article-title: Analysis of global systolic and diastolic left ventricular performance using volume-time curves by real-time three-dimensional echocardiography
  publication-title: J Am Soc Echocardiogr
  doi: 10.1067/mje.2003.40
– volume: 29
  start-page: 1043
  year: 2013
  end-page: 1050
  ident: CR15
  article-title: Effects of weight loss on myocardial energetics and diastolic function in obesity
  publication-title: Int J Cardiovasc Imaging
  doi: 10.1007/s10554-012-0174-6
– volume: 51
  start-page: 241
  year: 2001
  end-page: 247
  ident: CR28
  article-title: Ketone bodies, potential therapeutic uses
  publication-title: IUBMB Life
  doi: 10.1080/152165401753311780
– volume: 2
  start-page: 317
  year: 1993
  end-page: 321
  ident: CR36
  article-title: Obesity and the heart
  publication-title: Heart Dis Stroke
– volume: 109
  start-page: 2191
  year: 2004
  end-page: 2196
  ident: CR31
  article-title: Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000127959.28627.F8
– volume: 80
  start-page: 736
  year: 1997
  end-page: 740
  ident: CR2
  article-title: Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(97)00505-5
– volume: 321
  start-page: 225
  year: 2001
  end-page: 236
  ident: CR35
  article-title: Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome
  publication-title: Am J Med Sci
  doi: 10.1097/00000441-200104000-00003
– volume: 112
  start-page: 1019
  year: 2013
  end-page: 1024
  ident: CR33
  article-title: Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2013.05.036
– volume: 3
  start-page: 266
  year: 2010
  end-page: 274
  ident: CR37
  article-title: The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA)
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2009.10.012
– volume: 97
  start-page: 1784
  year: 2000
  end-page: 1789
  ident: CR50
  article-title: Lipotoxic heart disease in obese rats: implications for human obesity
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.97.4.1784
– volume: 40
  start-page: 879
  year: 2008
  end-page: 891
  ident: CR25
  article-title: Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models
  publication-title: Behav Res Methods
  doi: 10.3758/BRM.40.3.879
– volume: 8
  start-page: 1468
  year: 2015
  end-page: 1470
  ident: CR17
  article-title: Evidence of a direct effect of myocardial steatosis on LV hypertrophy and diastolic dysfunction in adult and adolescent obesity
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2014.12.019
– volume: 72
  start-page: 101
  year: 2006
  end-page: 111
  ident: CR45
  article-title: Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2006.06.024
– volume: 43
  start-page: 1399
  year: 2004
  end-page: 1404
  ident: CR9
  article-title: Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.10.062
– volume: 101
  start-page: 13624
  year: 2004
  end-page: 13629
  ident: CR49
  article-title: Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0405499101
– volume: 47
  start-page: 320
  year: 2005
  end-page: 332
  ident: CR3
  article-title: Epidemiology of diastolic heart failure
  publication-title: Prog Cardiovasc Dis
  doi: 10.1016/j.pcad.2005.02.010
– volume: 297
  start-page: E578
  year: 2009
  end-page: E591
  ident: CR29
  article-title: The Randle cycle revisited: a new head for an old hat
  publication-title: Am J Physiol-Endocrinol Metab
  doi: 10.1152/ajpendo.00093.2009
– volume: 93
  start-page: 800
  year: 1996
  end-page: 809
  ident: CR48
  article-title: Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined and evaluation
  publication-title: Circulation
  doi: 10.1161/01.CIR.93.4.800
– volume: 11
  start-page: 9
  year: 2009
  ident: CR5
  article-title: Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1186/1532-429X-11-9
– volume: 90
  start-page: 4087
  year: 2005
  end-page: 4093
  ident: CR38
  article-title: Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1963
– volume: 118
  start-page: 1736
  year: 2016
  end-page: 1751
  ident: CR34
  article-title: Lipid use and misuse by the heart
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.306842
– volume: 7
  start-page: 43
  year: 2013
  end-page: 50
  ident: CR13
  article-title: Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography
  publication-title: Clin Med Insights Cardiol
– volume: 65
  start-page: 44
  year: 2015
  end-page: 52
  ident: CR23
  article-title: Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus
  publication-title: Eur Heart J
– volume: 93
  start-page: 277
  year: 2003
  end-page: 279
  ident: CR42
  article-title: The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000089255.37804.72
– volume: 167
  start-page: 905
  year: 2012
  end-page: 909
  ident: CR52
  article-title: Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2012.03.104
– volume: 356
  start-page: 1140
  year: 2007
  end-page: 1151
  ident: CR26
  article-title: The failing heart—an engine out of fuel
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra063052
– volume: 278
  start-page: H1345
  year: 2000
  end-page: H1351
  ident: CR30
  article-title: Myocardial substrate metabolism influences left ventricular energetics
  publication-title: Am J Physiol-Heart Circulat Physiol
  doi: 10.1152/ajpheart.2000.278.4.H1345
– volume: 34
  start-page: 292
  year: 2013
  end-page: 299
  ident: CR16
  article-title: Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehs341
– volume: 69
  start-page: 716
  year: 2006
  end-page: 725
  ident: CR41
  article-title: Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2005.11.022
– volume: 167
  start-page: 905
  year: 2012
  ident: BFijo2017239_CR52
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2012.03.104
– volume: 72
  start-page: 101
  year: 2006
  ident: BFijo2017239_CR45
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2006.06.024
– volume: 3
  start-page: 266
  year: 2010
  ident: BFijo2017239_CR37
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2009.10.012
– volume: 1801
  start-page: 338
  year: 2010
  ident: BFijo2017239_CR32
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbalip.2009.12.006
– volume: 109
  start-page: 2191
  year: 2004
  ident: BFijo2017239_CR31
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000127959.28627.F8
– volume: 321
  start-page: 225
  year: 2001
  ident: BFijo2017239_CR35
  publication-title: Am J Med Sci
  doi: 10.1097/00000441-200104000-00003
– volume: 29
  start-page: 1043
  year: 2012
  ident: BFijo2017239_CR51
  publication-title: Int J Cardiovasc Imaging
  doi: 10.1007/s10554-012-0174-6
– volume: 13
  start-page: 200
  year: 2011
  ident: BFijo2017239_CR22
  publication-title: Eur J Heart Fail
  doi: 10.1093/eurjhf/hfq159
– volume: 90
  start-page: 4087
  year: 2005
  ident: BFijo2017239_CR38
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1963
– volume: 11
  start-page: 393
  year: 1997
  ident: BFijo2017239_CR47
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.11.4.9907
– volume: 145
  start-page: 1550
  year: 2004
  ident: BFijo2017239_CR43
  publication-title: Endocrinology
  doi: 10.1210/en.2003-1128
– volume: 43
  start-page: 1399
  year: 2004
  ident: BFijo2017239_CR9
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.10.062
– volume: 7
  start-page: 43
  year: 2013
  ident: BFijo2017239_CR13
  publication-title: Clin Med Insights Cardiol
– volume: 47
  start-page: 320
  year: 2005
  ident: BFijo2017239_CR3
  publication-title: Prog Cardiovasc Dis
  doi: 10.1016/j.pcad.2005.02.010
– volume: 101
  start-page: 13624
  year: 2004
  ident: BFijo2017239_CR49
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0405499101
– volume: 34
  start-page: 292
  year: 2013
  ident: BFijo2017239_CR16
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehs341
– volume: 118
  start-page: 1736
  year: 2016
  ident: BFijo2017239_CR34
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.306842
– volume: 89
  start-page: 1152
  year: 2003
  ident: BFijo2017239_CR12
  publication-title: Heart
  doi: 10.1136/heart.89.10.1152
– volume: 69
  start-page: 716
  year: 2006
  ident: BFijo2017239_CR41
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2005.11.022
– volume: 347
  start-page: 305
  year: 2002
  ident: BFijo2017239_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa020245
– volume: 98
  start-page: 116
  year: 2006
  ident: BFijo2017239_CR4
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.01.063
– volume: 66
  start-page: 619
  year: 2011
  ident: BFijo2017239_CR21
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.23011
– volume: 34
  start-page: 168
  year: 2006
  ident: BFijo2017239_CR27
  publication-title: Biochem Mol Biol Educ
  doi: 10.1002/bmb.2006.49403403168
– volume: 37
  start-page: 972
  year: 2013
  ident: BFijo2017239_CR18
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2012.170
– volume: 275
  start-page: 14563
  year: 2000
  ident: BFijo2017239_CR46
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.19.14563
– volume: 297
  start-page: E578
  year: 2009
  ident: BFijo2017239_CR29
  publication-title: Am J Physiol-Endocrinol Metab
  doi: 10.1152/ajpendo.00093.2009
– volume: 112
  start-page: 1019
  year: 2013
  ident: BFijo2017239_CR33
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2013.05.036
– volume: 97
  start-page: 1784
  year: 2000
  ident: BFijo2017239_CR50
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.97.4.1784
– volume: 278
  start-page: H1345
  year: 2000
  ident: BFijo2017239_CR30
  publication-title: Am J Physiol-Heart Circulat Physiol
  doi: 10.1152/ajpheart.2000.278.4.H1345
– volume: 292
  start-page: H2387
  year: 2007
  ident: BFijo2017239_CR44
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00579.2006
– volume: 16
  start-page: 29
  year: 2003
  ident: BFijo2017239_CR19
  publication-title: J Am Soc Echocardiogr
  doi: 10.1067/mje.2003.40
– volume: 93
  start-page: 1569
  year: 2004
  ident: BFijo2017239_CR8
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.02.073
– volume: 29
  start-page: 1043
  year: 2013
  ident: BFijo2017239_CR15
  publication-title: Int J Cardiovasc Imaging
  doi: 10.1007/s10554-012-0174-6
– volume: 125
  start-page: 1511
  year: 2012
  ident: BFijo2017239_CR11
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.069518
– volume: 8
  start-page: 1468
  year: 2015
  ident: BFijo2017239_CR17
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2014.12.019
– volume: 65
  start-page: 44
  year: 2015
  ident: BFijo2017239_CR23
  publication-title: Eur Heart J
– volume: 60
  start-page: 645
  year: 1976
  ident: BFijo2017239_CR7
  publication-title: Am J Med
  doi: 10.1016/0002-9343(76)90499-X
– volume: 54
  start-page: 718
  year: 2009
  ident: BFijo2017239_CR10
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.02.086
– volume: 2
  start-page: 317
  year: 1993
  ident: BFijo2017239_CR36
  publication-title: Heart Dis Stroke
– volume: 9
  start-page: pii: e002883
  year: 2016
  ident: BFijo2017239_CR14
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.115.002883
– volume: 36
  start-page: 198
  year: 2016
  ident: BFijo2017239_CR20
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.115.306561
– volume: 80
  start-page: 736
  year: 1997
  ident: BFijo2017239_CR2
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(97)00505-5
– volume: 40
  start-page: 879
  year: 2008
  ident: BFijo2017239_CR25
  publication-title: Behav Res Methods
  doi: 10.3758/BRM.40.3.879
– volume: 14
  start-page: 860
  year: 1964
  ident: BFijo2017239_CR6
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(64)90014-1
– volume: 93
  start-page: 800
  year: 1996
  ident: BFijo2017239_CR48
  publication-title: Circulation
  doi: 10.1161/01.CIR.93.4.800
– volume: 287
  start-page: H2877
  year: 2004
  ident: BFijo2017239_CR40
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00499.2004
– volume: 93
  start-page: 277
  year: 2003
  ident: BFijo2017239_CR42
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000089255.37804.72
– volume: 51
  start-page: 241
  year: 2001
  ident: BFijo2017239_CR28
  publication-title: IUBMB Life
  doi: 10.1080/152165401753311780
– volume: 97
  start-page: 203
  year: 2011
  ident: BFijo2017239_CR39
  publication-title: Heart
  doi: 10.1136/hrt.2009.185009
– volume: 356
  start-page: 1140
  year: 2007
  ident: BFijo2017239_CR26
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra063052
– volume: 11
  start-page: 9
  year: 2009
  ident: BFijo2017239_CR5
  publication-title: J Cardiovasc Magn Reson
  doi: 10.1186/1532-429X-11-9
– volume: 98
  start-page: 1083
  year: 2012
  ident: BFijo2017239_CR24
  publication-title: Heart
  doi: 10.1136/heartjnl-2012-302145
– reference: 31227797 - Int J Obes (Lond). 2019 Aug;43(8):1652. doi: 10.1038/s41366-019-0404-2.
SSID ssj0005502
ssj0033214
Score 2.481178
Snippet Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is...
Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined...
Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is...
Background:Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 441
SubjectTerms 59/57
692/499
692/699/75
Abnormalities
Adult
Body mass
Body Mass Index
Cardiovascular diseases
Cohort Studies
Diastole (Cardiac cycle)
Diastole - physiology
Epidemiology
Female
Health aspects
Health Promotion and Disease Prevention
Health risks
Heart diseases
Heart function
Humans
Hypertrophy
Internal Medicine
Intra-Abdominal Fat - diagnostic imaging
Intra-Abdominal Fat - physiopathology
Magnetic Resonance Imaging
Magnetic resonance spectroscopy
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Metabolism
Obesity
Obesity - diagnostic imaging
Obesity - epidemiology
Obesity - physiopathology
Original
original-article
Physiological aspects
Public Health
Risk analysis
Risk factors
Steatosis
Strain rate
Triglycerides
Triglycerides - blood
Ventricle
Ventricular Dysfunction, Left - diagnostic imaging
Ventricular Dysfunction, Left - physiopathology
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLguXRQAEjQTmgQDaO4_iEKqCqkNoTlfZmOX6URdukKAGJf8-M42SbFXDblWe9juezZyYef0PIKzAblhkIcqThOi2ckKn2SwaftKsy6TMfagOenpUn58WXFV_FF25dTKsc98SwUdvW4DtyCNIh3M55tWQfrn6kWDUKT1djCY2b5BZSlyGqxUpsUzx4NnFJMazIM7IigtXnMQs-Y9X79Xe8BrgU73KsGX7NPu3u0tfM1G4K5c45ajBPx_fI3ehX0qMBCPfJDdcsSPJp7Xp6SCP554aejdz7C3L7NJ6qL8hi6zuCcKh73j0gF4AgOlx1-eVoSGmPtbFo6-ml6wE-m7WhurF0YKFFBg-q6wbd4E1gaqV9SwGA4GCipP3doRkNXayhl6EmwUNyfvz568eTNJZlSA2EN33qra-FdJrxui5qxrypvNa2ZEJnxlqYEnA5ZZ5rZkrtmWHSwtyWNejHCwbu5SOy17SN2ye0qiAarXO59LUspLXQi9Qi1yW3woDrmZC3ozKUiZzlWDpjo8LZOasUqE6h6hSoLiGvJ-mrgavjH3IvUK9quGk6LXF1xMGXLRh4nQl5EyRwkcP_GR3vKsCokS5rJnkwk4TFaebNI3ZU3Bw6tYVyQl5OzfhLTHhrXPuzUyAhMnAVRZaQxwPUpmeCGBmCwCJPiJiBcBJAyvB5S7P-FqjDOWzXvII-D0e4bof1t6l68v_xPyV34Es15OQdkD0Am3sGTlpfPw8r8Q9FCjsp
  priority: 102
  providerName: ProQuest
Title The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
URI https://link.springer.com/article/10.1038/ijo.2017.239
https://www.ncbi.nlm.nih.gov/pubmed/28974742
https://www.proquest.com/docview/2019425813
https://www.proquest.com/docview/1947097670
https://pubmed.ncbi.nlm.nih.gov/PMC5880580
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_uA0QQ0fpVPdcIej549bpN0ySPu-sth3CLiAf7VtKk0T3WrrBV8L93kn6sXRR8aQuZzqbJJDOzmfkNwCtUG4ZqdHKkZipKSy4jZccUn1QpYmlj62sDXi2yy-v0w5ItD-Csy4XxQfse0tJv01102PnqxmXqjfm7hMpDOHag7c7VmmWzXUAHi3vkKOrq73QYiKjjWRvzHlMxYDXQRvt78h9KaT9gcu_U1Cuj-T2421qRZNL0-z4clFUA4ftVWZNT0kJ9rsmiQ9oP4NZVe4YewJ3mnzrSJCAFEOwsR3zZVz3fPoAvKD-kSXT5WRIf0N5WxiIbS76VNQqP46IqQxoMWoffQVRROSN47XFaSb0hKH5oXjpK82vrlKhnsUIuTUWCh3A9v_g8u4zaogyRRuemjqyxBZeloqwo0oJSq4VVymSUq1gbg0OEBqdMEkV1pizVVBoc66yQTFpO0bh8BEfVpiqfABECfdEikWNbyFQag1yk4onKmOEaDc8Q3naTk-sWsdwVzljn_uScihynMndTmeNUhvC6p_7eIHX8g-6Fm-e8yTPtF3g-YWjJphRtzhDeeAq3xPH3tGozFbDXDixrQHkyoMSlqYfNnSzl7dawdf2QuFGKMX7fy77ZvenC3apy82ObIwWP0VDkcQiPG9Hrvwk9ZHQB0yQEPhDKnsABhg9bqtVXDxzOcLNmAnmeduK769bfhurp_xI-g9v4KJrYvBM4QrErn6OxVhcjOORLjlcxG4_geDKfThd4n14sPn4a-fX7G23_QO4
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VRQIuCMJroVAj0XJAC5v1Ors-IFS1VCltcmql3ozXDwgKm6IEUP8Uv5EZ76NJBNx6i-SJ482MZ75Zj78BeIlhw3KDSY40QseZy2WsfZ_jJ-2KRPrEh96Ao_FgeJZ9PBfnG_C7vQtDZZWtTwyO2s4MvSPHJB3T7VQUff7-4ntMXaPodLVtoVGbxbG7_IUp2_zd0QHqdydNDz-c7g_jpqtAbBCdL2JvfZlLp7koy6zk3JvCa20HPNeJsdYah4hJpqnmZqA9N1xatNpBKYX0ORf0AhRd_o2M49akm-n7SyUlIum4qzh1AGpZGBFliKbqPuHF28lXunbYz9-k1KN8KR6uR4WlsLhesrl2bhvC4eFduNPgWLZXG9492HBVD6KDiVuwXdaQjU7ZuOX678HNUXOK34PeFVZF4dBnfX4fPqPFsvpqzU_HQgl904uLzTz75hZortOJYbqyrGa9JcYQpsuKYPc0MMOyxYyhwSOgJUl7OaewHaaY4Cx1D4QHcHYtCnsIm9Wsco-BFQVmv2Uq-76UmbQWZ5E6T_VA2Nwg1I3gdasMZRqOdGrVMVXhrJ4XClWnSHUKVRfBTid9UXOD_ENum_Sq6putnUtRewKxc8YR5UbwKkiQU8HfM7q5G4GrJnquFcmtFUl0BmZ1uLUd1TijubraOhG86Ibpm1RgV7nZj7lCiTxBaJonETyqTa17JszJMenM0gjyFSPsBIiifHWkmnwJVOUCw4MocM7d1lyvlvW3v-rJ_9e_DbeGp6MTdXI0Pn4Kt3GgqOsBt2ATDc89Q4C4KJ-HXcng03W7gT94PXny
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VRaq4IAivhUKNRMsBLd2s17F9QKhqqFpKIw5U6s14_YCgsClKAPWv8esYex95CLj1FsUTx8mMZ75Zj78BeI5hw1KDSY40TKeF4zLVvk_xlXYikz7zsTfg2WhwfF68u2AXG_C7vQsTyipbnxgdtZ2a8Iwck3RMt3Mm-nTfN2URH4ZHby6_p6GDVDhpbdtp1CZy6q5-Yfo2e30yRF3v5vnR24-Hx2nTYSA1iNTnqbe-5NJpysqyKCn1Rnit7YBynRlrrXGInmSea2oG2lNDpUULHpSSSc8pCw9D0f3f4JSLsMfE4VJ5Ccs6HisaugG1jIyIOFhTgZ9RsT_-Gq4g9vmrPPQrX4qN6xFiKUSul2-uneHG0Hh0G241mJYc1EZ4BzZc1YNkOHZzskca4tEJGbW8_z3YOmtO9HvQW-BWFI4912d34TNaL6mv2fx0JJbTN325yNSTb26OpjsZG6IrS2oG3MAeQnRZBQg-iSyxZD4laPwIboOkvZqFEB6nGOMsdT-Ee3B-LQq7D5vVtHIPgQiBmXCZy74vZSGtxVmk5rkeMMsNwt4EXrbKUKbhSw9tOyYqnttToVB1KqhOoeoS2O2kL2uekH_I7QS9qvqWa-de1AFDHF1QRLwJvIgSwcHg9xnd3JPAVQeqrhXJ7RVJdAxmdbi1HdU4pplabKMEnnXD4ZOh2K5y0x8zhRI8Q5jKswQe1KbW_SbMzzEBLfIE-IoRdgKBrnx1pBp_ibTlDEMFEzjnXmuui2X97a969P_178AWOgD1_mR0-hhu4vuiLg3chk20O_cEseK8fBo3JYFP1-0F_gAWCH4o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relative+contribution+of+metabolic+and+structural+abnormalities+to+diastolic+dysfunction+in+obesity&rft.jtitle=International+Journal+of+Obesity&rft.au=Rayner%2C+J+J&rft.au=Banerjee%2C+R&rft.au=Holloway%2C+C+J&rft.au=Lewis%2C+A+J+M&rft.date=2018-03-01&rft.pub=Nature+Publishing+Group&rft.issn=0307-0565&rft.volume=42&rft.issue=3&rft.spage=441&rft_id=info:doi/10.1038%2Fijo.2017.239&rft.externalDocID=A532643009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon